FCM
HZNP
Frontier Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-488,015
| Closed | -$30.2M | – | 285 |
|
2022
Q3 | $30.2M | Buy |
488,015
+112,843
| +30% | +$6.98M | 0.35% | 109 |
|
2022
Q2 | $29.9M | Sell |
375,172
-319,569
| -46% | -$25.5M | 0.34% | 107 |
|
2022
Q1 | $73.1M | Sell |
694,741
-124,569
| -15% | -$13.1M | 0.66% | 42 |
|
2021
Q4 | $88.3M | Sell |
819,310
-9,343
| -1% | -$1.01M | 0.7% | 38 |
|
2021
Q3 | $90.8M | Sell |
828,653
-49,492
| -6% | -$5.42M | 0.71% | 37 |
|
2021
Q2 | $82.2M | Sell |
878,145
-6,879
| -0.8% | -$644K | 0.6% | 51 |
|
2021
Q1 | $81.5M | Sell |
885,024
-217,243
| -20% | -$20M | 0.62% | 50 |
|
2020
Q4 | $80.6M | Sell |
1,102,267
-237,398
| -18% | -$17.4M | 0.6% | 46 |
|
2020
Q3 | $104M | Buy |
1,339,665
+117,310
| +10% | +$9.11M | 0.91% | 24 |
|
2020
Q2 | $67.9M | Buy |
+1,222,355
| New | +$67.9M | 0.6% | 56 |
|